Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.
No sampling. All eligible patients will be included.
Observational Model: Cohort, Time Perspective: Retrospective
Overall survival from initiation of first systemic anticancer therapy
Pfizer CT.gov Call Center
Denmark: Danish Medicines Agency